Want to join the conversation?
$MDXG said it has agreed to terms of settlement with each of Medline Industries and Liventa Bioscience for false advertising claims asserted against each of them by $MDXG. In April 2014, $MDXG filed a lawsuit in Northern District Court of Georgia against Musculoskeletal Transplant Foundation, Medline, and Liventa for permanent injunctive relief.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.